Molecular Docking and ADMET Prediction of Small Molecules Targeting Proteins Involved in Alzheimer’s Disease
AppliedChem · 04.06.2026 · 6 (2) · 39
DOI: 10.3390/appliedchem6020039 ↗Kurz gefasst
Fachartikel in der Zeitschrift AppliedChem, online erschienen am 04.06.2026. Verfasst von Emilio Mateev und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian National Science Fund.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by the accumulation of the toxic protein amyloid-β, formation of tau-containing neurofibrillary tangles, neuroinflammation, and synaptic dysfunction, highlighting the need for new therapeutic strategies capable of modulating multiple pathological pathways simultaneously. In this study, a structure-based in silico approach was applied to evaluate the multi-target potential of two previously reported pyrrole-based compounds (pyrrole 1 and pyrrole 2) with known monoamine oxidase-B (MAO-B) inhibitory activity and low neurotoxicity. Molecular docking studies were performed against a panel of key AD-related targets, including GSK-3β, APP, MAO-B, BACE1, AChE, BChE, COX-2, GABA-B receptor, NMDA receptor, and E3 ubiquitin ligase CHIP, using Glide XP docking. The results revealed that compound pyrrole 1 may have favorable predicted binding affinities across several targets, with relatively strong docking scores for GSK-3β and COX-2. The binding mode analysis indicated that pyrrole 1 adopts poses consistent with interaction patterns commonly observed for ATP-competitive GSK-3β inhibitors and COX-2 ligands. In silico ADMET profiling using the software SwissADME and ProTox 3.0 indicated distinct pharmacokinetic and safety profiles for the two compounds, with pyrrole 2 showing superior drug-likeness and predicted blood–brain barrier penetration, while pyrrole 1 displayed a more favorable overall toxicity profile. Collectively, these findings identify pyrrole 1 as a theoretically promising multi-target candidate for AD requiring experimental validation, while providing a strong structural basis for further optimizations and subsequent experimental confirmation.
Förderung
- Bulgarian National Science Fund
Zitieren
APA
Mateev, E., Kostov, S., Karatchobanov, V., Kondeva-Burdina, M., & Georgieva, M. (2026). Molecular Docking and ADMET Prediction of Small Molecules Targeting Proteins Involved in Alzheimer’s Disease. AppliedChem, 6(2), 39. https://doi.org/10.3390/appliedchem6020039
Vancouver
Mateev E, Kostov S, Karatchobanov V, Kondeva-Burdina M, Georgieva M. Molecular Docking and ADMET Prediction of Small Molecules Targeting Proteins Involved in Alzheimer’s Disease. AppliedChem. 2026;6(2):39. doi:10.3390/appliedchem6020039
BibTeX
@article{Mateev2026,
author = {Mateev, Emilio and Kostov, Stefan and Karatchobanov, Valentin and Kondeva-Burdina, Magdalena and Georgieva, Maya},
title = {Molecular Docking and ADMET Prediction of Small Molecules Targeting Proteins Involved in Alzheimer’s Disease},
journal = {AppliedChem},
year = {2026},
volume = {6},
number = {2},
pages = {39},
doi = {10.3390/appliedchem6020039}
}
EUVIMED